2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -83.28%1-Year Change
- Medical Care FacilitiesIndustry
Basel Med (BMGL)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 76
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
BMGL Regains Compliance With Nasdaq Minimum Bid Price Requirement
Basel Medical Group Ltd (BMGL) announced on July 10, 2026 that it has regained compliance with Nasdaq's minimum bid price rule of $1.00 per share. The company had been notified of non-compliance in January 2026 but successfully maintained the required minimum closing bid price for 10 consecutive business days from June 23-July 7, 2026.
07/10/2026, 6:30 AM • GlobeNewswire
BMGL to Effect Reverse Share Split on June 22, 2026
Basel Medical Group Ltd (Nasdaq: BMGL), a Singapore-based medical clinic operator, announced a 1-for-12 reverse stock split effective June 22, 2026, to comply with Nasdaq's minimum bid price requirement of $1 per share. The consolidation will reduce outstanding shares from approximately 18.8 million to 1.6 million shares.
06/10/2026, 7:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 07/13/2026
Company Profile
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental health, woman's health, and general practice services. In addition, its services include consultation, medical diagnosis, and medical and surgical treatments. The company was incorporated in 2023 and is headquartered in Singapore.
Key Executives
- Jianing Lu
- Keng Leong Fung
- Boon Chye Tan
- Yen Feng Chhoa
- Chun How Neo
Current Ownership Distribution
- Insiders20.4M (99.74%)
- Institutions53,812 (0.26%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)